139 related articles for article (PubMed ID: 19404734)
1. Association of genetic variation in mitotic kinases with breast cancer risk.
Wang X; Fredericksen ZS; Vierkant RA; Kosel ML; Pankratz VS; Cerhan JR; Justenhoven C; Brauch H; ; Olson JE; Couch FJ
Breast Cancer Res Treat; 2010 Jan; 119(2):453-62. PubMed ID: 19404734
[TBL] [Abstract][Full Text] [Related]
2. Variation in genes required for normal mitosis and risk of breast cancer.
Olson JE; Wang X; Goode EL; Pankratz VS; Fredericksen ZS; Vierkant RA; Pharoah PD; Cerhan JR; Couch FJ
Breast Cancer Res Treat; 2010 Jan; 119(2):423-30. PubMed ID: 19377877
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer.
Stevens KN; Wang X; Fredericksen Z; Pankratz VS; Cerhan J; Vachon CM; Olson JE; Couch FJ
Breast Cancer Res Treat; 2011 Sep; 129(2):617-22. PubMed ID: 21607584
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility.
Lo YL; Yu JC; Chen ST; Hsu GC; Mau YC; Yang SL; Wu PE; Shen CY
Carcinogenesis; 2007 May; 28(5):1079-86. PubMed ID: 17210994
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK.
Lo YL; Yu JC; Chen ST; Yang HC; Fann CS; Mau YC; Shen CY
Int J Cancer; 2005 Jun; 115(2):276-83. PubMed ID: 15688402
[TBL] [Abstract][Full Text] [Related]
6. Centrosome-related genes, genetic variation, and risk of breast cancer.
Olson JE; Wang X; Pankratz VS; Fredericksen ZS; Vachon CM; Vierkant RA; Cerhan JR; Couch FJ
Breast Cancer Res Treat; 2011 Jan; 125(1):221-8. PubMed ID: 20508983
[TBL] [Abstract][Full Text] [Related]
7. Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis.
Li JJ; Li SA
Pharmacol Ther; 2006 Sep; 111(3):974-84. PubMed ID: 16603252
[TBL] [Abstract][Full Text] [Related]
8. Coding region polymorphisms in the CHFR mitotic stress checkpoint gene are associated with colorectal cancer risk.
Kang HC; Kim IJ; Jang SG; Hong SH; Hwang JA; Shin HR; Park JG
Cancer Lett; 2008 Feb; 260(1-2):170-9. PubMed ID: 18079053
[TBL] [Abstract][Full Text] [Related]
9. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.
Garcia-Closas M; Kristensen V; Langerød A; Qi Y; Yeager M; Burdett L; Welch R; Lissowska J; Peplonska B; Brinton L; Gerhard DS; Gram IT; Perou CM; Børresen-Dale AL; Chanock S
Int J Cancer; 2007 Dec; 121(11):2532-8. PubMed ID: 17683073
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk.
Vaclavicek A; Bermejo JL; Wappenschmidt B; Meindl A; Sutter C; Schmutzler RK; Kiechle M; Bugert P; Burwinkel B; Bartram CR; Hemminki K; Försti A
Breast Cancer Res Treat; 2007 Dec; 106(2):205-13. PubMed ID: 17268814
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.
Nyante SJ; Gammon MD; Kaufman JS; Bensen JT; Lin DY; Barnholtz-Sloan JS; Hu Y; He Q; Luo J; Millikan RC
Cancer Causes Control; 2015 Jan; 26(1):121-31. PubMed ID: 25421376
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.
Purrington KS; Slettedahl S; Bolla MK; Michailidou K; Czene K; Nevanlinna H; Bojesen SE; Andrulis IL; Cox A; Hall P; Carpenter J; Yannoukakos D; Haiman CA; Fasching PA; Mannermaa A; Winqvist R; Brenner H; Lindblom A; Chenevix-Trench G; Benitez J; Swerdlow A; Kristensen V; Guénel P; Meindl A; Darabi H; Eriksson M; Fagerholm R; Aittomäki K; Blomqvist C; Nordestgaard BG; Nielsen SF; Flyger H; Wang X; Olswold C; Olson JE; Mulligan AM; Knight JA; Tchatchou S; Reed MW; Cross SS; Liu J; Li J; Humphreys K; Clarke C; Scott R; ; Fostira F; Fountzilas G; Konstantopoulou I; Henderson BE; Schumacher F; Le Marchand L; Ekici AB; Hartmann A; Beckmann MW; Hartikainen JM; Kosma VM; Kataja V; Jukkola-Vuorinen A; Pylkäs K; Kauppila S; Dieffenbach AK; Stegmaier C; Arndt V; Margolin S; ; ; Balleine R; Arias Perez JI; Pilar Zamora M; Menéndez P; Ashworth A; Jones M; Orr N; Arveux P; Kerbrat P; Truong T; Bugert P; Toland AE; Ambrosone CB; Labrèche F; Goldberg MS; Dumont M; Ziogas A; Lee E; Dite GS; Apicella C; Southey MC; Long J; Shrubsole M; Deming-Halverson S; Ficarazzi F; Barile M; Peterlongo P; Durda K; Jaworska-Bieniek K; Tollenaar RA; Seynaeve C; ; Brüning T; Ko YD; Van Deurzen CH; Martens JW; Kriege M; Figueroa JD; Chanock SJ; Lissowska J; Tomlinson I; Kerin MJ; Miller N; Schneeweiss A; Tapper WJ; Gerty SM; Durcan L; Mclean C; Milne RL; Baglietto L; dos Santos Silva I; Fletcher O; Johnson N; Van'T Veer LJ; Cornelissen S; Försti A; Torres D; Rüdiger T; Rudolph A; Flesch-Janys D; Nickels S; Weltens C; Floris G; Moisse M; Dennis J; Wang Q; Dunning AM; Shah M; Brown J; Simard J; Anton-Culver H; Neuhausen SL; Hopper JL; Bogdanova N; Dörk T; Zheng W; Radice P; Jakubowska A; Lubinski J; Devillee P; Brauch H; Hooning M; García-Closas M; Sawyer E; Burwinkel B; Marmee F; Eccles DM; Giles GG; Peto J; Schmidt M; Broeks A; Hamann U; Chang-Claude J; Lambrechts D; Pharoah PD; Easton D; Pankratz VS; Slager S; Vachon CM; Couch FJ
Hum Mol Genet; 2014 Nov; 23(22):6034-46. PubMed ID: 24927736
[TBL] [Abstract][Full Text] [Related]
14. Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome.
Couch FJ; Wang X; Bamlet WR; de Andrade M; Petersen GM; McWilliams RR
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):251-7. PubMed ID: 20056645
[TBL] [Abstract][Full Text] [Related]
15. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
16. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations.
Raskin L; Pinchev M; Arad C; Lejbkowicz F; Tamir A; Rennert HS; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1060-5. PubMed ID: 18483326
[TBL] [Abstract][Full Text] [Related]
17. A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk.
Talbott KE; Gammon MD; Kibriya MG; Chen Y; Teitelbaum SL; Long CM; Gurvich I; Santella RM; Ahsan H
Breast Cancer Res Treat; 2008 Oct; 111(3):481-7. PubMed ID: 17975727
[TBL] [Abstract][Full Text] [Related]
18. Targeting TAO Kinases Using a New Inhibitor Compound Delays Mitosis and Induces Mitotic Cell Death in Centrosome Amplified Breast Cancer Cells.
Koo CY; Giacomini C; Reyes-Corral M; Olmos Y; Tavares IA; Marson CM; Linardopoulos S; Tutt AN; Morris JDH
Mol Cancer Ther; 2017 Nov; 16(11):2410-2421. PubMed ID: 28830982
[TBL] [Abstract][Full Text] [Related]
19. Mitotic kinases as drivers of the epithelial-to-mesenchymal transition and as therapeutic targets against breast cancers.
Colón-Marrero S; Jusino S; Rivera-Rivera Y; Saavedra HI
Exp Biol Med (Maywood); 2021 May; 246(9):1036-1044. PubMed ID: 33601912
[TBL] [Abstract][Full Text] [Related]
20. Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer.
Lin WY; Brock IW; Connley D; Cramp H; Tucker R; Slate J; Reed MW; Balasubramanian SP; Cannon-Albright LA; Camp NJ; Cox A
PLoS One; 2013; 8(7):e68578. PubMed ID: 23844225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
